• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种与肿瘤免疫细胞浸润及卵巢癌患者预后相关的氧化应激相关基因的临床预后模型。

A clinical prognostic model of oxidative stress-related genes linked to tumor immune cell infiltration and the prognosis of ovarian cancer patients.

作者信息

Li Li, Zhang Weiwei, Sun Yanjun, Zhang Weiling, Lu Mengmeng, Wang Jiaqian, Jin Yunfeng, Xi Qinghua

机构信息

Department of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, 226001, China.

Department of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu, 226001, China.

出版信息

Heliyon. 2024 Mar 21;10(7):e28442. doi: 10.1016/j.heliyon.2024.e28442. eCollection 2024 Apr 15.

DOI:10.1016/j.heliyon.2024.e28442
PMID:38560253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10981114/
Abstract

BACKGROUND

According to statistics, ovarian cancer (OV) is the most prevalent type of gynecologic malignancy and has the highest mortality rate of all gynecologic tumors. Although several studies have shown that oxidative stress (OS) contributes significantly to the onset and progression of cancer, the role of OS in OV needs to be investigated further. Thus, it is critical to comprehend the function of OS-related genes in OV.

METHODS

In this study, all data related to the transcriptome and clinical status of the patients were retrieved from "The Cancer Genome Atlas" (TCGA) and "Gene Expression Omnibus" (GEO) databases. Using the unsupervised cluster analysis technique, all patients with OV were classified into two different subtypes (categories) based on the OS gene. All hub genes were screened using the weighted gene co-expression network analysis (WGCNA). Since the hub genes and the differentially expressed genes (DEGs) in both categories were found to intersect, the univariate Cox regression analysis was implemented. A multivariate Cox analysis was also performed to construct a novel clinical prognosis model, which was validated using data from the GEO cohort. In addition, the relationship between risk score and immune cell infiltration level was evaluated using CIBERSORT. Finally, qRT-PCR was used to confirm the expression of the genes used to construct the model.

RESULTS

Two subtypes of OS were obtained. The findings indicated that OS-C1 had a better survival outcome than OS-C2. The results of WGCNA yielded 112 hub genes. For univariate COX regression analyses, 49 OS-related trait genes were obtained. Finally, a clinical prognostic model containing two genes was constructed. This model could differentiate between patients with OV having varying years of survival in the TCGA and GEO cohorts. The model risk score was verified as an independent prognostic indicator. According to the results of CIBERSORT, many tumor-infiltrating immune cells were found to be significantly related to the risk score. Furthermore, the results revealed that patients with low-risk OV in the CTLA4 treatment group had a high likelihood of benefiting from immunotherapy. qRT-PCR results also showed that the expression of and was high in the OV samples.

CONCLUSIONS

Analysis of the results suggested that the newly developed model, which contained two characteristic OS-related genes, could successfully predict the survival outcomes of all patients with OV. The findings of this study could offer valuable information and insights into the refinement of personalized therapy and immunotherapy for OV in the future.

摘要

背景

据统计,卵巢癌(OV)是最常见的妇科恶性肿瘤类型,在所有妇科肿瘤中死亡率最高。尽管多项研究表明氧化应激(OS)对癌症的发生和发展有显著影响,但OS在OV中的作用仍需进一步研究。因此,了解OS相关基因在OV中的功能至关重要。

方法

在本研究中,所有与患者转录组和临床状态相关的数据均从“癌症基因组图谱”(TCGA)和“基因表达综合数据库”(GEO)中检索。使用无监督聚类分析技术,根据OS基因将所有OV患者分为两种不同的亚型(类别)。使用加权基因共表达网络分析(WGCNA)筛选所有枢纽基因。由于发现两类中的枢纽基因和差异表达基因(DEG)存在交集,因此进行了单变量Cox回归分析。还进行了多变量Cox分析以构建新的临床预后模型,并使用来自GEO队列的数据进行验证。此外,使用CIBERSORT评估风险评分与免疫细胞浸润水平之间的关系。最后,使用qRT-PCR确认用于构建模型的基因的表达。

结果

获得了OS的两种亚型。研究结果表明,OS-C1的生存结果优于OS-C2。WGCNA的结果产生了112个枢纽基因。对于单变量COX回归分析,获得了49个与OS相关的性状基因。最后,构建了一个包含两个基因的临床预后模型。该模型可以区分TCGA和GEO队列中生存年限不同的OV患者。模型风险评分被验证为独立的预后指标。根据CIBERSORT的结果,发现许多肿瘤浸润免疫细胞与风险评分显著相关。此外,结果显示CTLA4治疗组中低风险OV患者从免疫治疗中获益的可能性很高。qRT-PCR结果还表明, 和 在OV样本中的表达较高。

结论

对结果的分析表明,新开发的包含两个与OS相关特征基因的模型可以成功预测所有OV患者的生存结果。本研究结果可为未来OV个性化治疗和免疫治疗的优化提供有价值的信息和见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0320/10981114/10c3edb1df47/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0320/10981114/943d678c40c8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0320/10981114/b59e5820d4d9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0320/10981114/de35aa7cc0d2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0320/10981114/f2c1fb21aea5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0320/10981114/e5e402c76933/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0320/10981114/9d2cf76f4fc7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0320/10981114/52b2707e1c73/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0320/10981114/10c3edb1df47/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0320/10981114/943d678c40c8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0320/10981114/b59e5820d4d9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0320/10981114/de35aa7cc0d2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0320/10981114/f2c1fb21aea5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0320/10981114/e5e402c76933/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0320/10981114/9d2cf76f4fc7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0320/10981114/52b2707e1c73/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0320/10981114/10c3edb1df47/gr8.jpg

相似文献

1
A clinical prognostic model of oxidative stress-related genes linked to tumor immune cell infiltration and the prognosis of ovarian cancer patients.一种与肿瘤免疫细胞浸润及卵巢癌患者预后相关的氧化应激相关基因的临床预后模型。
Heliyon. 2024 Mar 21;10(7):e28442. doi: 10.1016/j.heliyon.2024.e28442. eCollection 2024 Apr 15.
2
Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.基于单细胞 RNA 测序和 bulk RNA 测序综合分析建立卵巢癌腹膜转移相关预后模型。
J Ovarian Res. 2022 Nov 23;15(1):123. doi: 10.1186/s13048-022-01059-0.
3
Prognostic model development and molecular subtypes identification in bladder urothelial cancer by oxidative stress signatures.基于氧化应激特征的膀胱癌预后模型建立及分子亚型鉴定
Aging (Albany NY). 2024 Feb 1;16(3):2591-2616. doi: 10.18632/aging.205499.
4
Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.鉴定胃癌中与铜死亡相关的亚型,构建预后模型和肿瘤微环境景观。
Front Immunol. 2022 Nov 21;13:1056932. doi: 10.3389/fimmu.2022.1056932. eCollection 2022.
5
A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.一种基于新型肿瘤突变负担的风险模型可预测卵巢癌的预后,并与免疫浸润相关。
Front Immunol. 2022 Aug 8;13:943389. doi: 10.3389/fimmu.2022.943389. eCollection 2022.
6
Oxidative Stress Response Biomarkers of Ovarian Cancer Based on Single-Cell and Bulk RNA Sequencing.基于单细胞和批量 RNA 测序的卵巢癌氧化应激反应生物标志物。
Oxid Med Cell Longev. 2023 Jan 27;2023:1261039. doi: 10.1155/2023/1261039. eCollection 2023.
7
Assessing of programmed cell death gene signature for predicting ovarian cancer prognosis and treatment response.评估细胞程序性死亡基因特征预测卵巢癌预后和治疗反应。
Front Endocrinol (Lausanne). 2023 Jun 5;14:1182776. doi: 10.3389/fendo.2023.1182776. eCollection 2023.
8
Identification of necroptosis subtypes and development of necroptosis-related risk score model for in ovarian cancer.卵巢癌中坏死性凋亡亚型的鉴定及坏死性凋亡相关风险评分模型的建立
Front Genet. 2022 Dec 8;13:1043870. doi: 10.3389/fgene.2022.1043870. eCollection 2022.
9
A Novel Platinum Resistance-Related Immune Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer.一种新型铂类耐药相关免疫基因标志物,用于预测卵巢癌患者的总生存期。
Biochem Genet. 2024 Feb;62(1):112-124. doi: 10.1007/s10528-023-10379-9. Epub 2023 Jun 4.
10
Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.结肠癌中缺氧相关亚型的鉴定、预后模型的建立及肿瘤微环境浸润特征
Front Genet. 2022 Jun 17;13:919389. doi: 10.3389/fgene.2022.919389. eCollection 2022.

引用本文的文献

1
MARVELD1 Promotes the Invasiveness in Pancreatic Adenocarcinoma through the Activation of Epithelial-to-Mesenchymal Transition.MARVELD1通过激活上皮-间质转化促进胰腺腺癌的侵袭性。
Protein Pept Lett. 2025;32(3):224-233. doi: 10.2174/0109298665359781250114055525.
2
Identification and validation of an m7G-related lncRNAs signature for predicting prognosis, immune response and therapy landscapes in ovarian cancer.用于预测卵巢癌预后、免疫反应和治疗前景的m7G相关长链非编码RNA特征的鉴定与验证
Front Genet. 2024 Oct 8;15:1466422. doi: 10.3389/fgene.2024.1466422. eCollection 2024.

本文引用的文献

1
Unlocking Exosome-Based Theragnostic Signatures: Deciphering Secrets of Ovarian Cancer Metastasis.解锁基于外泌体的治疗诊断标志物:解读卵巢癌转移的秘密。
ACS Omega. 2023 Oct 1;8(40):36614-36627. doi: 10.1021/acsomega.3c02837. eCollection 2023 Oct 10.
2
Optimizing hybrid vigor: a comprehensive analysis of genetic distance and heterosis in eggplant landraces.优化杂种优势:茄子地方品种遗传距离与杂种优势的综合分析
Front Plant Sci. 2023 Aug 31;14:1238870. doi: 10.3389/fpls.2023.1238870. eCollection 2023.
3
Plasma Modification Techniques for Natural Polymer-Based Drug Delivery Systems.
基于天然聚合物的药物递送系统的等离子体改性技术
Pharmaceutics. 2023 Aug 1;15(8):2066. doi: 10.3390/pharmaceutics15082066.
4
Unveiling the connection: Long-chain non-coding RNAs and critical signaling pathways in breast cancer.揭示关联:长链非编码 RNA 与乳腺癌关键信号通路
Pathol Res Pract. 2023 Sep;249:154736. doi: 10.1016/j.prp.2023.154736. Epub 2023 Aug 3.
5
Janus Kinase-Signal Transducer and Activator of Transcription Inhibitors for the Treatment and Management of Cancer.Janus 激酶 - 信号转导和转录激活因子抑制剂在癌症治疗和管理中的应用。
J Environ Pathol Toxicol Oncol. 2023;42(4):15-29. doi: 10.1615/JEnvironPatholToxicolOncol.2023045403.
6
The regulation loop of MARVELD1 interacting with PARP1 in DNA damage response maintains genome stability and promotes therapy resistance of cancer cells.MARVELD1 与 PARP1 在 DNA 损伤反应中的调控环维持基因组稳定性并促进癌细胞的治疗抵抗性。
Cell Death Differ. 2023 Apr;30(4):922-937. doi: 10.1038/s41418-023-01118-z. Epub 2023 Feb 7.
7
V-Set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy.V -set 及免疫球蛋白结构域包含蛋白(VSIG)作为癌症免疫治疗中的新兴免疫检查点靶点。
Front Immunol. 2022 Sep 15;13:938470. doi: 10.3389/fimmu.2022.938470. eCollection 2022.
8
Focusing the pivotal role of nanotechnology in Huntington's disease: an insight into the recent advancements.聚焦纳米技术在亨廷顿病中的关键作用:对最新进展的洞察。
Environ Sci Pollut Res Int. 2022 Oct;29(49):73809-73827. doi: 10.1007/s11356-022-22830-2. Epub 2022 Sep 14.
9
Mechanisms of β-adrenergic receptors agonists in mediating pro and anti-apoptotic pathways in hyperglycemic Müller cells.β-肾上腺素能受体激动剂在介导高血糖状态下米勒细胞促凋亡和抗凋亡途径中的机制。
Mol Biol Rep. 2022 Oct;49(10):9473-9480. doi: 10.1007/s11033-022-07816-0. Epub 2022 Aug 4.
10
Investigating the Effect of Estradiol Levels on the Risk of Breast, Endometrial, and Ovarian Cancer.研究雌二醇水平对乳腺癌、子宫内膜癌和卵巢癌风险的影响。
J Endocr Soc. 2022 Jun 29;6(8):bvac100. doi: 10.1210/jendso/bvac100. eCollection 2022 Aug 1.